BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 25400456)

  • 1. GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells.
    Xin XM; Zhong MX; Yang GL; Peng Y; Zhang YL; Zhu W
    World J Gastroenterol; 2014 Nov; 20(42):15727-35. PubMed ID: 25400456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of farnesoid X receptor agonist on adiponectin and its receptors].
    Xin X; Zhong M; Zhang S; Peng Y; Zhu W; Zhang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jan; 34(1):109-12. PubMed ID: 24463129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclolepis genistoides D. Don (palo azul) promotes differentiation of adipocytes and regulates adipokine expression.
    Sato H; Ishikawa M; Funaki A; Kimura Y; Yoshida H; Fukata H; Hasegawa H; Ueno K
    Nutr Res; 2013 Nov; 33(11):922-31. PubMed ID: 24176232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
    Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
    Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes.
    Kudoh A; Satoh H; Hirai H; Watanabe T
    Life Sci; 2011 Jun; 88(23-24):1055-62. PubMed ID: 21514306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the new C1q/TNF-related protein (CTRP-3) "cartonectin" on the adipocytic secretion of adipokines.
    Wölfing B; Buechler C; Weigert J; Neumeier M; Aslanidis C; Schöelmerich J; Schäffler A
    Obesity (Silver Spring); 2008 Jul; 16(7):1481-6. PubMed ID: 18421280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-silico therapeutic investigations of arjunic acid and arjungenin as an FXR agonist and validation in 3T3-L1 adipocytes.
    T MM; T A; P BK; Fathima A; Khanum F
    Comput Biol Chem; 2020 Feb; 84():107163. PubMed ID: 31767507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 17β-estradiol and progesterone on the production of adipokines in differentiating 3T3-L1 adipocytes: Role of Rho-kinase.
    Pektaş M; Kurt AH; Ün İ; Tiftik RN; Büyükafşar K
    Cytokine; 2015 Apr; 72(2):130-4. PubMed ID: 25647267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expressions of leptin and adiponectin receptor isoforms in chronic myeloid leukemia patients.
    Ozturk K; Avcu F; Ural AU
    Cytokine; 2012 Jan; 57(1):61-7. PubMed ID: 22082804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-abundant adiponectin receptors in visceral adipose tissue of humans and rats are further reduced in diabetic animals.
    Bauer S; Weigert J; Neumeier M; Wanninger J; Schäffler A; Luchner A; Schnitzbauer AA; Aslanidis C; Buechler C
    Arch Med Res; 2010 Feb; 41(2):75-82. PubMed ID: 20470935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GW4064, an agonist of farnesoid X receptor, represses CYP3A4 expression in human hepatocytes by inducing small heterodimer partner expression.
    Zhang S; Pan X; Jeong H
    Drug Metab Dispos; 2015 May; 43(5):743-8. PubMed ID: 25725071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycine increases mRNA adiponectin and diminishes pro-inflammatory adipokines expression in 3T3-L1 cells.
    Garcia-Macedo R; Sanchez-Muñoz F; Almanza-Perez JC; Duran-Reyes G; Alarcon-Aguilar F; Cruz M
    Eur J Pharmacol; 2008 Jun; 587(1-3):317-21. PubMed ID: 18499099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
    Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
    Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1q/TNF-related protein 3 expression and effects on adipocyte differentiation of 3T3-L1 cells.
    Nishimoto H; Yamamoto A; Furukawa S; Wakisaka S; Maeda T
    Cell Biol Int; 2017 Feb; 41(2):197-203. PubMed ID: 27590487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of rapamycin on cholesterol homeostasis and secretory function of 3T3-L1 cells].
    Li JH; Liu YJ; Zhang GJ; Yin HC; Tao JL; Li H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):560-5. PubMed ID: 22338143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes.
    Fasshauer M; Klein J; Kralisch S; Klier M; Lössner U; Blüher M; Paschke R
    FEBS Lett; 2004 Jan; 558(1-3):27-32. PubMed ID: 14759511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis.
    Haga S; Yimin ; Ozaki M
    BMC Gastroenterol; 2017 Jan; 17(1):9. PubMed ID: 28086800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTRP3 modulates the expression and secretion of adipokines in 3T3-L1 adipocytes.
    Li X; Jiang L; Yang M; Wu YW; Sun SX; Sun JZ
    Endocr J; 2014; 61(12):1153-62. PubMed ID: 25168658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Carotene accumulation in 3T3-L1 adipocytes inhibits the elevation of reactive oxygen species and the suppression of genes related to insulin sensitivity induced by tumor necrosis factor-α.
    Kameji H; Mochizuki K; Miyoshi N; Goda T
    Nutrition; 2010; 26(11-12):1151-6. PubMed ID: 20097535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models.
    Ahmad A; Ali T; Kim MW; Khan A; Jo MH; Rehman SU; Khan MS; Abid NB; Khan M; Ullah R; Jo MG; Kim MO
    Metabolism; 2019 Jan; 90():31-43. PubMed ID: 30473057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.